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Introduction Hospital Course
Diffuse alveolar hemorrhage (DAH) is the process of bleeding into the alveolar 
spaces of the lungs due to disruption of the alveolar-capillary basement 
membrane. It can be caused by many disease processes, including rheumatic 
diseases, vasculitis, infection, drugs, etc4. DAH is a rare, but serious pulmonary 
complication of systematic lupus erythematosus1. Cough, hemoptysis, fever, and 
dyspnea are common initial symptoms, however, hemoptysis can be absent in up 
to one third of patients3. In the absence of hemoptysis, new radiographic 
opacities, decreasing hemoglobin level, and the finding of hemorrhagic fluid on 
bronchoalveolar lavage favor the diagnosis5.
CC: “Persistent fever, rash, cough”
HPI: 22 year old female G1P0 14 weeks pregnant is presenting to the ED with 
chief complaint of fevers, body aches, lesions on the hand and in the mouth x2 
weeks. Patient states that she was diagnosed with hand-foot-mouth disease, 12 
days ago, states that since then has been having high fevers.  Patient denies any 
severe headaches, neck pain, chest pain, shortness of breath. Patient is a current 
tobacco abuser. Patient denies any drug use or alcohol abuse. Patient has no 
other medical problems. Followed up with her Ob two days ago, US of baby wnl
per patient. Patient denies having any abdominal cramping or vaginal bleeding or 
discharge.
ROS: Positive for fatigue, myalgia, fevers, rash, cough
Vitals: BP 112/62 mmHg | Pulse 142 | 39.9ºC | RR 20 | SpO2 100%
Physical Examination: 
Constitutional: Well-developed and well-nourished. Alert.
Eyes: Pupils are equal, round, and reactive to light. EOM are normal.
Throat: Pustules noted over roof of mouth
Neck: Normal range of motion and full passive range of motion without pain. No 
neck rigidity.
Cardiovascular: Tachycardia, no murmurs 
Pulmonary/Chest: Effort normal and breath sounds normal. No respiratory 
distress.
Abdominal: Soft. Bowel sounds are normal. She exhibits no distension. There is 
no tenderness. There is no rebound and no guarding. 
Musculoskeletal: Normal range of motion. 
Neurological: AAOX3. 5/5 strength B/L UE and LE. No cranial nerve deficit. 
Negative finger to nose test 
Skin: Pustules/erythematous lesion noted on palms of bilateral hands, elbows, 
and lesions surrounding chin, on face, no evidence of sloughing of skin, no signs 
of burns noted
Resources
Not Your Typical Pneumonia
Shama Patel D.O., Scott Sipp, MD, Emergency Medicine, 
Henry Ford Health System, Detroit, Michigan 
Henry Ford Macomb ED Course 10/13/2018:
On initial presentation, a code sepsis was called based on presenting vitals –
blood cultures, UA, CBC, BMP, Coags, CXR, lactic acid, influenza, 
monospot, and strep culture were ordered. 30 cc/kg fluid bolus and Tylenol 
was ordered. 
Labs significant for:
WBC: 3.3  Hgb: 8.3  Lactic Acid: 2.7 Na:129 K: 3.1
Patient initially improved clinically, lactic acid cleared after fluid bolus, 
however during the ED course, patient became hypoxic on room air at 88%, 
improved with 2 L of oxygen when sitting upright, patient felt short of breath 
lying flat, patient had bilateral coarse breath sounds, worse on the right, chest 
x-ray was repeated, BNP and troponin obtained. Patient's repeat chest x-ray 
showed worsening right lung interstitial pattern, concerns for pneumonia, at 
this time sepsis identified, IV Rocephin and IV azithromycin were started and 
patient was admitted for further evaluation. 
Henry Ford Macomb Hospital Course 10/14/18-10/15/2018: 
Patient continued to have recurrent fevers and tachycardia, repeat troponin 
was ordered, elevated at 110, peaked at 250 then trended down, likely 
secondary to NSTEMI type 2. ECHO 10/14/18 : EF: 57%. No evidence of 
ischemic, valvular, hypertrophic, or pulmonary heart disease. 
17:48 
Rapid response is called for tachypnea and tachycardia, patient was febrile 
102.8F, HR 130s-140, blood pressure stable, sinus tachycardia on EKG, 
patient complained of positional chest pain at that time, patient was 
transferred to the ICU for further monitoring.
10/15/18
Per ID notes, there was concern for disseminated zoster as patient was not 
improving on antibiotics, started on acyclovir. Due to patient being a high risk 
pregnancy, with worsening respiratory status, requiring HFNC – decision was 
made to transfer to Henry Ford Main
Case Presentation
Henry Ford Main Hospital Course:
Patient was transferred to HF Main MICU for escalation of care on 10/15/18. A 
multidisciplinary approach was taken with ID, Rheumatology, Dermatology, 
Nephrology, Hematology, and Maternal Fetal Medicine. Skin biopsies were 
collected, with samples positive for cutaneous lupus, patient was started 
on Methylprednisone 1g x 3 days and then Prednisone 70mg. Patient’s 
respiratory status deteriorated, she was intubated on 10/17/18. Bronchoscopy on 
10/18/18 demonstrated diffuse alveolar hemorrhage – six rounds of 
plasmapheresis were completed. Given the patient’s severe symptoms 
secondary to SLE, Cytoxan therapy was initiated along with prophylactic 
Bactrim. Patient was cleared for discharge home with close follow up with her 
OB/Gyn and Rheumatology team.
Throughout the hospital course, patient had an extensive immunological, 
hematological, and infectious work up, which was all negative except the 
following: ANA 1:640 speckled, low complements C3 and C4,  RNP +, Smith+, 
DAT+ Mycoplasma IgG
Discussion
DAH is a difficult diagnosis; clinical suspicion needs to be high. DAH 
accounts for only for 1.5 to 3.7% of hospital admission due to SLE2. In this 
particular case, when you look at the presentation of this patient, it classically 
fits DAH. The patient appeared to have pneumonia, however, clinical 
symptoms were not improving with antibiotics and continued to have 
infiltrates on imaging, her skin biopsies and lab work was consistent with 
SLE, and her BAL revealed hemorrhage fluid. This case was particularly 
difficult, as patient did not present with hemoptysis, she did not have a known 
diagnosis of SLE, she was pregnant, and had a complicated clinical course. 
DAH has a high mortality rate, 25-50%, therefore, it is imperative to 
diagnosis and treat early4. Treatment for DAH related to SLE includes a 
combination of systemic glucocorticoids and immunosuppressive therapy, 
rituximab, or plasmapheresis, and support care3. 
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